Investigating the long-term effects of child health programs in Kenya
Experimental Evidence on Long-run and Intergenerational Impacts of Child Health Investments in the Kenya Life Panel Survey (KLPS)
This study looks at how a school program that helps kids get rid of worms can improve their health, education, and overall quality of life as they grow up, and it’s for families interested in how early health support can make a difference for their children in the long run.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project ID | NIH-10926855 on NIH RePORTER |
What this research studies
This research examines how a child health program, specifically a primary school-based deworming initiative, impacts various life outcomes such as living standards, health, and education over the long term. By analyzing data from the Kenya Life Panel Survey, which includes information on over 6,500 individuals and their children, the study aims to understand the intergenerational effects of health interventions. The research will track participants from childhood into adulthood, focusing on how early health improvements influence later life choices and outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 3-9 years old whose parents participated in the deworming program and are part of the Kenya Life Panel Survey.
Not a fit: Patients who are not part of the Kenya Life Panel Survey or who did not receive the deworming intervention may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide insights into how investing in child health can lead to improved life outcomes for future generations.
How similar studies have performed: Previous research has shown success in understanding the long-term impacts of health interventions, making this approach both relevant and promising.
Where this research is happening
Berkeley, United States
- University of California Berkeley — Berkeley, United States (Active)
Researchers
- Principal investigator: Miguel, Edward Andrew — University of California Berkeley
- Study coordinator: Miguel, Edward Andrew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.